Richard Barry, Director at Sarepta Therapeutics, Inc. (SRPT), bought 75,000 shares at $15.66 ($1.2M) on 2016-03-14, disclosed to the SEC on 2016-03-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| SAVA | BUY | 2025-11-24 | $828K | — | Filing → |
| SAVA | BUY | 2025-11-20 | $404K | — | Filing → |
| SAVA | BUY | 2025-09-23 | $16K | — | Filing → |